Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 November 2024 | Story Leonie Bolleurs | Photo Supplied
BOOTES-6 telescope station
The BOOTES-6 telescope station captured a South African sighting of the southern lights, a rare atmospheric phenomenon powered by solar activity.

The northern lights, with their vibrant displays of green, pink, and violet hues, have become a famous attraction in Nordic countries. But in early October, a rare sighting of the southern lights – or aurora australis – was reported in South Africa, surprising many.

Prof Pieter Meintjes, Professor in the Department of Physics at the University of the Free State (UFS), explains that both the northern and southern lights are the result of charged particles from coronal mass ejections (CMEs) on the sun, which are captured by Earth’s magnetic field. "The interaction between magnetic fields and charged particles, such as protons and electrons, is very interesting. The magnetic field forces these particles to spiral around the field lines, ultimately guiding them towards the magnetic poles. As these particles enter Earth’s atmosphere, they collide with atmospheric atoms, causing a beautiful glow. The colours of the aurora indicate which atoms are involved. Typically, hydrogen shines red, while oxygen and nitrogen produce a greenish-blue tinge," he says.

Observing the southern lights

When the display occurs above the northern magnetic pole, it is called the aurora borealis (northern lights) and can typically be observed over regions such as Alaska, Greenland, and the Nordic countries. Above the southern magnetic pole, it is known as aurora australis (southern lights), usually visible over places such as Antarctica and New Zealand. “In extreme cases – when gigantic mass ejections occurred – it can also be observed in mid-latitudes such as South Africa,” says Prof Meintjes.

This recent and rare South African sighting was also captured by the BOOTES-6 telescope station at Boyden Observatory, located just outside Bloemfontein. According to Prof Meintjes, the telescope station has an all-sky monitor – a camera constantly watching the sky for changes and monitoring, among others, cloud cover to ensure that the telescope is always safe from weather. While the monitor was taking photos of the night sky, Prof Alberto Castro-Tirado, a research professor at the Institute of Astrophysics of Andalusia in Spain, picked up the aurora.

The Institute of Astrophysics of Andalusia in Spain, in collaboration with the University College Dublin (UCD), is partnering with the UFS in a research-driven initiative involving the BOOTES-6 telescope station, installed in 2022 during the COVID-19 pandemic. Under a Memorandum of Understanding that was recently renewed for another five years, the UFS and UCD share approximately 30% of the telescope's observing time dedicated to UFS research.

“The DPRT telescope (Dolores Pérez-Ramírez telescope), named after a Spanish astronomer and lecturer at the University of Jaén, contributes significantly to our research, with publications resulting from contributions made by the telescope station and collaborators on gamma-ray bursts, occultations, and transient events co-authored by me and a colleague in the department, Dr Hendrik van Heerden,” notes Prof Meintjes.

Research-driven initiatives

Data from the telescope station is also used for their in-house projects and contributes significantly to the work of their PhD students that will be submitted in the next few years. This includes the PhD work of Helene Szegedi, who uses data from the BOOTES-6 telescope station to study cataclysmic variable systems – compact binaries that erupt regularly. Another PhD student, Joleen Barnard, studies blazar variability under the guidance of Prof Brian van Soelen. Blazars, explains Prof Meintjes, are the core of distant galaxies powered by supermassive black holes. These cosmic jets are pointed towards Earth, but fortunately, they are millions or billions of light years away; otherwise, their impact would be devastating to life on Earth.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept